Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children. (18th May 2020)

• Record Type: Journal Article
• Authors: Marks, Michael; Gwyn, Sarah; Toloka, Hilary; Kositz, Christian; Asugeni, James; Asugeni, Rowena; Diau, Jason; Kaldor, John M; Romani, Lucia; Redman-MacLaren, Michelle; MacLaren, David; Solomon, Anthony W; Mabey, David C W; Steer, Andrew C; Martin, Diana
• Is Part Of: Clinical infectious diseases. Volume 71:Number 12(2020)
• Page Start: 3226
• Page End: 3228
• Publication Date: 2020-05-18
• Subjects: scabies -- neglected tropical diseases -- ivermectin -- Strongyloides; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciaa584
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: The prevalence of antibodies to Strongyloides stercoralis was measured in 0–12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA ( P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.